ClinicalTrials.gg
Not yet recruitingNCT07098221H2RESTUpdated Aug 1, 2025

Hydrogen-Rich Water and Resting Metabolism in Young Adults

An interventional study of Molecular Hydrogen and Placebo Comparator in Healthy Subjects or Volunteers, sponsored by University of Novi Sad. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-01.

Sponsored by University of Novi Sad · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The H2REST trial is a randomized, double-blind, placebo-controlled crossover study investigating the acute effects of a single dose of hydrogen-rich water (HRW) on resting metabolism in healthy young adults. Participants complete two testing sessions-receiving either HRW or placebo in a randomized order-followed by standardized metabolic testing. Primary outcomes include resting energy expenditure, respiratory exchange ratio, and substrate utilization measured via indirect calorimetry. The study aims to assess whether acute HRW intake can modulate metabolic rate and fuel preference at rest, and to explore inter-individual variability in response.

02

Conditions studied

  • Healthy Subjects or Volunteers

Keywords

  • Hydrogen-rich water
  • Resting metabolism
  • Energy expenditure
  • Substrate utilization
  • Metabolic rate
03

In context

Lead sponsor

University of Novi Sad is the lead sponsor of 28 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-35 years
  • between 18.5 and 25.0 kg/m²
  • Apparently healthy, with no history of chronic disease
  • Non-smoker, not currently using nicotine-containing products
  • Able to provide
  • Willing to refrain from alcohol, caffeine, and strenuous exercise for 24 hours before each study visit
  • Able to comply with study procedures, including fasting and attending all study visits

Exclusion criteria

Exclusion Criteria:

  • Diagnosed metabolic, cardiovascular, respiratory, gastrointestinal, or endocrine disorders
  • Use of dietary supplements or medications affecting metabolism (within the past 2 weeks)
  • Allergy or intolerance to components of the hydrogen or placebo beverages
  • Pregnant or lactating
  • Shift work or irregular sleep schedule
  • Participation in another clinical study within the past 30 days
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    ARM1: 250 ml of Hydrogen Rich Water

    Hydrogen-producing tablets: Tablets designed to dissolve in water and release molecular hydrogen gas, creating hydrogen-rich water that can be consumed to potentially provide antioxidant and anti-inflammatory benefits.

    Dietary Supplement: Molecular Hydrogen

  • Placebo comparator
    ARM 2: 250 ml of Placebo Water (Non-hydrogen-producing tablets)

    Non-hydrogen-producing tablets, identical in appearance and taste to the active supplement

    Dietary Supplement: Placebo Comparator

Interventions

  • Dietary supplementHydrogenStudies of HydrogenHydrogen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Participants in this arm will consume a single 250 mL dose of hydrogen-rich water containing approximately 1.6-2.0 ppm of dissolved molecular hydrogen (H₂), The HRW will be ingested following an overnight fast, and resting metabolism will be measured approximately 30-60 minutes post-consumption using indirect calorimetry.

  • Dietary supplementPlacebo Comparator

    Non-hydrogen-producing tablets, identical in appearance and taste to the active supplement

06

What researchers measure

Primary outcomes

  1. Resting Energy Expenditure (REE)

    The measurements will be obtained during each study visit. Since this is an interventional study assessing the acute effects of molecular hydrogen, measurements will be collected three times: At baseline, without any intervention (pre-familiarization), After a single dose of molecular hydrogen, and After placebo administration. The period between each intervention will be seven days, serving as a washout period to prevent carry-over effects. All participants will be instructed to maintain their regular diet and to avoid alcohol, caffeine-containing beverages, and strenuous physical activity for at least 24 hours prior to each visit. Measure Type: Continuous (kcal/day) Method: Indirect calorimetry Description: To assess the effect of acute ingestion of hydrogen-rich water versus placebo on resting energy expenditure in healthy young adults.

    Time frame: Participants will attend three study visits, with each intervention separated by a 7-day washout period to minimize carry-over effects. During each visit, measurements will be conducted approximately 30-60 minutes post-intervention.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2025; primary completion for Dec 2025, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 17, 2025
First posted
Aug 1, 2025
StartEst.
Sep 1, 2025
Primary completionEst.
Dec 1, 2025
CompletionEst.
Dec 1, 2025
Last update
Aug 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07098221
Lead sponsor
University of Novi Sad
Responsible party
Nikola Todorovic (Teaching assistant, PhD, University of Novi Sad) — Principal investigator
First posted
Aug 1, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Dec 1, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Aug 1, 2025

Study contacts

Nikola Todorovic, PhD
Contact
nikolatodorovic1708@gmail.com
+381658417576

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Hydrogen

Start the discussion